Posterior Reversible Encephalopathy Syndrome Clinical Trial
Official title:
Inflammatory Biomarkers for the Diagnosis of Obstetric Posterior Reversible Encephalopathy Syndrome
The purpose of this study is to explore the inflammatory biomarkers for the diagnosis of obstetric posterior reversible encephalopathy syndrome.
The investigators retrospectively collected data (General information, clinical data, biochemical indicators, imaging features, and pregnancy outcome) from pregnant woman diagnosed with PRES to explore the inflammatory biomarkers for the diagnosis of oPRES during 2012 to 2021.Then, the investigators grouped all the patients into PRES group (PE or E with PRES) and NOT-PRES group (PE or E without PRES) according to the diagnostic criteria of PRES. Then, the investigators analysed the inflammatory biomarkers, such as neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), monocyte-lymphocyte ratio (MLR), and so on of two groups, and compared the difference of tow groups. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05143710 -
The Clinical and Prognostic Features of PRES
|
||
| Recruiting |
NCT03470467 -
Posterior Reversible Encephalopathy Syndrome in the Critically Ill Patients
|
||
| Recruiting |
NCT04950270 -
Copeptin Kinetics in Critically Ill Patients With Posterior Reversible Encephalopathy Syndrome
|
||
| Not yet recruiting |
NCT05140850 -
Long-term Consequences of Neuroimaging and Perceived Cognitive Dysfunction in oPRES
|
||
| Recruiting |
NCT02665598 -
Prognostic Observation of Posterior Reversible Encephalopathy Syndrome
|
||
| Completed |
NCT05310513 -
The Predictors of ICU Admission of oPRES
|